Manganese accumulation in bone following chronic exposure in rats: Steady-state concentration and half-life in bone

Toxicology Letters

Volumn 229, Issue 1, 2014, Pages 93-100

  O'Neal, Stefanie L ^a   Hong, Lan ^a   Fu, Sherleen ^a   Jiang, Wendy ^a   Jones, Alexander ^a   Nie, Linda H ^a   Zheng, Wei ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

Biomarker; Bone; Disposition; Half life; Manganese

Indexed keywords

BIOLOGICAL MARKER; MANGANESE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCULATION; CONTROLLED STUDY; CORPUS STRIATUM; ENVIRONMENTAL EXPOSURE; FEMUR; HALF LIFE TIME; HIPPOCAMPUS; HUMERUS; LONG TERM EXPOSURE; MALE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; STEADY STATE;

BIOMARKER; BONE; DISPOSITION; HALF-LIFE; MANGANESE;

ALGORITHMS; ANIMALS; BODY WEIGHT; BONE AND BONES; BRAIN; CENTRAL NERVOUS SYSTEM; HALF-LIFE; KINETICS; MAGNESIUM CHLORIDE; MALE; MANGANESE; METALS; MUSCLE, SKELETAL; ORGAN SIZE; PHARMACOKINETICS; RATS; RATS, SPRAGUE-DAWLEY; SPECTROPHOTOMETRY, ATOMIC; TISSUE DISTRIBUTION;

EID: 84902479822     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2014.06.019     Document Type: Article

References (46)

1. Andersen M.E., Gearhart J.M., Clewell H.J. Pharmacokinetic data needs to support risk assessments for inhaled and ingested manganese. Neurotoxicology 1999, 20:161-171.
2. Apostoli P., Lucchini R., Alessio L. Are current biomarkers suitable for the assessment of manganese exposure in individual workers?. Am. J. Ind. Med. 2000, 37:283-290.
3. Aschner M., Guilarte T.R., Schneider J.S., Zheng W. Manganese: recent advances in understanding its transport and neurotoxicity. Toxicol. Appl. Pharmacol. 2007, 221:131-147.
4. Agency for Toxic Substances and Disease Registry (ATSDR) Toxicological Profile for Manganese 2012, U.S. Department of Health and Human Services, Public Health Service, Atlanta, GA.
5. Bancroft G.N., Sikavitsas V.I., van den Dolder J., Sheffield T.L., Ambrose C.G., Jansen J.A., Mikos A.G. Fluid flow increases mineralized matrix deposition in 3D perfusion culture of marrow stromal osteoblasts in a dose-dependent manner. PNAS 2002, 99(20):12600-12605.
6. Barbeau A., Inoué N., Cloutier T. Role of manganese in dystonia. Adv. Neurol. 1976, 14:339-352.
7. Bouchard M.F., Sauve S., Barbeau B., Legrand M., Brodeur M.E., Bouffard T., et al. Intellectual impairment in school-age children exposed to manganese from drinking water. Environ. Health Perspect. 2011, 119:138-143.
8. Butcher D.J., Zybin A., Bolshov M.A., Niemax K. Speciation of methylcyclopentadienyl manganese tricarbonyl by high-performance liquid chromatography-diode laser atomic absorption spectrometry. Anal. Chem. 1999, 71:5379-5385.
9. Chandra S.V., Shukla G.S., Srivastawa R.S., Singh H., Gupta V.P. An exploratory study of manganese exposure to welders. Clin. Toxicol. 1981, 18:407-418.
10. Crossgrove J., Zheng W. Manganese toxicity upon overexposure. NMR Biomed. 2004, 17:544-553.
11. DeWitt M.R., Chen P., Aschner M. Manganese efflux in parkinsonism: insights from newly characterized slc30a10 mutations. Biochem. Biophys. Res. Commun. 2013, 432:1-4.
12. Dorman D.C., McElveen A.M., Marshall M.W., Parkinson C.U., Arden James R., Struve M.F., et al. Maternal-fetal distribution of manganese in the rat following inhalation exposure to manganese sulfate. Neurotoxicology 2005, 26:625-632.
13. Dydak U., Jiang Y.M., Long L.L., Zhu H., Chen J., Li W.M., Edden R.A.E., Hu S., Fu X., Long Z.Y., Mo X.A., Meier D., Harezlak J., Aschner M., Murdoch J.B., Zheng W. In vivo measurement of brain gaba concentrations by magnetic resonance spectroscopy in smelters occupationally exposed to manganese. Environ. Health Perspect. 2011, 119:219-224.
14. Fujioka M., Taoka T., Matsuo Y., Mishima K., Ogoshi K., Kondo Y., Tsuda M., Fujiwara M., Asano T., Sakaki T., Miyasaki A., Park D., Siesjö B.K. Magnetic resonance imaging shows delayed ischemic striatal neurodegeneration. Ann. Neurol. 2003, 54(6):732-747.
15. Furchner J.E., Richmond C.R., Drake G.A. Comparative metabolism of radionuclides in mammals. 3. Retention of manganese-54 in the mouse, rat, monkey and dog. Health Phys. 1966, 12:1415-1423.
16. Gibaldi M., Perrier D. Pharmacokinetics 1982, Marcel Dekker, New York.
17. Hafeman D., Factor-Litvak P., Cheng Z., van Geen A., Ahsan H. Association between manganese exposure through drinking water and infant mortality in Bangladesh. Environ. Health Perspect. 2007, 115(7):1107-1112.
18. ICRP Report of the Task Group on Reference Man 1972, International Commission on Radiological Protection, New York, Publication no. 23.
19. Inoue N., Makita Y. Neurological aspects in human exposures to manganese. Toxicology of Metals 1996, 415-421. CRC Press, Boca Raton. L.W. Chang (Ed.).
20. Jiang Y., Zheng W., Long L., Zhao W., Li X., Mo X., Lu J.P., Fu X., Li W.M., Liu S.F., Long Q.Y., Huang J.L., Pira E. Brain magnetic resonance imaging and manganese concentrations in red blood cells of smelting workers: search for biomarkers of manganese exposure. Neurotoxicology 2007, 28:126-135.
21. Jiang Y.M., Mo X.A., Du F.Q., Fu X., Zhu X.Y., Gao H.Y., Xie J.L., Liao F.L., Pira E., Zheng W. Effective treatment of manganese-induced occupational parkinsonism with p-aminosalicylic acid: a case of 17-year follow-up study. J. Occup. Environ. Med. 2006, 48:644-649.
22. Kondakis X.G., Makris N., Leotsinidis M., Prinou M., Papapetropoulos T. Possible health effects of high manganese concentration in drinking water. Arch. Environ. Health 1989, 44(3):175-178.
23. Liu Y., Koltick D., Byrne P., Wang H., Zheng W., Nie L.H. Development of a transportable neutron activation analysis system to quantify manganese in bone in vivo: feasibility and methodology. Physiol. Meas. 2013, 34:1593-1609.
24. Lucchini R.G., Albini E., Benedetti L., Borghesi S., Coccaglio R., Malara E.C., et al. High prevalence of parkinsonian disorders associated to manganese exposure in the vicinities of ferroalloy industries. Am. J. Ind. Med. 2007, 50:788-800.
25. McMillian D.E. A brief history of the neurobehavioral toxicity of Mn: some unanswered questions. Neurotoxicology 1999, 20(2-3):499-508.
26. Newland M.C., Cox C., Hamada R., Oberdorster G., Weiss B. The clearance of manganese chloride in the primate. Fundam. Appl. Toxicol. 1987, 9:314-328.
27. O'Neal S., Lee J.-W., Zheng W., Cannon J.R. Subchronic manganese exposure in rats is a neurochemical model of early manganese toxicity. Neurotoxicology 2014, in revision.
28. Pejovic-Milic A., Chettle D.R., Oudyk J., Pysklywec M.W., Haines T. Bone manganese as a biomarker of manganese exposure: a feasibility study. Am. J. Ind. Med. 2009, 52:742-750.
29. Racette B.A., Aschner M., Guilarte T.R., Dydak U., Criswell S.R., Zheng W. Pathophysiology of manganese-associated neurotoxicity. Neurotoxicology 2012, 33(4):881-886.
30. Schroeder H.A., Balassa J.J., Tipton I.H. Essential trace metals in man: manganese. A study in homeostasis. J. Chronic Dis. 1966, 19:545-571.
31. Seaborn C.D., Nielsen F.H. Dietary silicon and arginine affect mineral element composition of rat femur and vertebra. Biol. Trace Elem. Res. 2002, 89:239-250.
32. Sengupta P. A scientific review of age determination for a laboratory rat: how old is it in comparison with human age?. Biomed. Int. 2011, 2:81-89.
33. Serrat M.A., Reno P.L., McCollum M.A., Meindl R.S., Lovejoy C.O. Variation in mammalian proximal femoral development: comparative analysis of two distinct ossification patterns. J. Anat. 2007, 210:249-258.
34. Sierra P., Loranger S., Kennedy G., Zayed J. Occupational and environmental exposure of automobile mechanics and nonautomotive workers to airborne manganese arising from the combustion of methylcyclopentadienyl manganese tricarbonyl (MMT). Am. Ind. Hyg. Assoc. J. 1995, 56:713-716.
35. Sikk K., Haldre S., Aquilonius S.M., Taba P. Manganese-induced Parkinsonism due to Ephedrone abuse. Parkinson's Disease 2011, 865319.
36. Tøndevold E., Eliasen P. Blood flow rates in canine cortical and cancellous bone measured with 99Tcm-labeled human albumin microspheres. Acta Orthop. Scand. 1982, 53:7-11.
37. Vezer T., Kurunczi A., Naray M., Papp A., Nagymajtenyi L. Behavioral effects of subchronic inorganic manganese exposure in rats. Am. J. Ind. Med. 2007, 50:841-852.
38. Wang L., Ohishi T., Shiraki A., Morita R., Akane H., Ikarashi Y., Mitsumori K., Shibutani M. Developmental exposure to manganese chloride induces sustained aberration of neurogenesis in the hippocampal dentate gyrus of mice. Toxicol. Sci. 2012, 127(2):508-521.
39. Zaichick S., Zaichick V., Karandashev V.K., Moskvina I.R. The effect of age and gender on 59 trace-element contents in human rib bone investigated by inductively coupled plasma mass spectrometry. Biol. Trace Elem. Res. 2011, 143:41-57.
40. Zheng W., Ren S., Graziano J.H. Manganese inhibits mitochondrial aconitase: a mechanism of manganese neurotoxicity. Brain Res. 1998, 799:334-342.
41. Zheng W., Kim H., Zhao Q. Comparative toxicokinetics of manganese chloride and methylcyclo-pentadienyl Mn tricarbonyl in male Sprague-Dawley rats. Toxicol. Sci. 2000, 54:295-301.
42. Zheng W. Neurotoxicology of the brain barrier system: new implications. J. Toxicol.-Clin. Toxicol. 2001, 39(7):711-719.
43. Zheng W., Aschner M., Ghersi-Egea J.F. Brain barrier systems: a new frontier in metal neurotoxicological research. Invited review. Toxicol. Appl. Pharmacol. 2003, 192:1-11.
44. Zheng W., Jiang Y.M., Zhang Y.S., Jiang W., Wang X., Cowan D.M. Chelation therapy of manganese intoxication by para-aminosalicylic acid (PAS) in Sprague-Dawley rats. Neurotoxicology 2009, 30:240-248.
45. Zheng W., Fu S.X., Dydak U., Cowan D.M. Biomarkers of manganese intoxication. Neurotoxicology 2011, 32:1-8.
46. Zheng W., Monnot A.D. Regulation of brain iron and copper homeostasis by brain barrier systems: implication in neurodegenerative diseases. Pharmacol. Ther. 2012, 133:177-188.